feed,title,long_url,short_url
SeekingAlpha,Rollins shares slid on pricing secondary stock offering at $35.00,https://seekingalpha.com/news/4009859,
SeekingAlpha,CymaBay says liver disease candidate outperformed in Phase 3 trial,https://seekingalpha.com/news/4009858,
SeekingAlpha,PIE Vs. VWO: EM Momentum Approach Radically Changes The Allocations,https://seekingalpha.com/article/4632801,
SeekingAlpha,"Realty Income: The Market Is Wrong, I Am Buying This 5.6% Yield Hand Over Fist",https://seekingalpha.com/article/4633658,
